MAMartin-Nizard

Martin-Nizard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin-Nizard has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Abdelmejid Kandoussi

    Departement de Recherche sur les Lipoprotéines et l'Athérosclérose, INSERM UR 545, Institut Pasteur et Faculté de Pharmacie, Université de Lille 2 , Lille

    1 shared publication
  • François Bailleul

    Laboratoire de Pharmacognosie, EA 1043, Faculté de Pharmacie, Université de Lille 2 , Lille

    1 shared publication
  • Jean-Charles Fruchart

    Departement de Recherche sur les Lipoprotéines et l'Athérosclérose, INSERM UR 545, Institut Pasteur et Faculté de Pharmacie, Université de Lille 2 , Lille

    1 shared publication
  • Marie Carpentier

    Laboratoire de Pharmacognosie, EA 1043, Faculté de Pharmacie, Université de Lille 2 , Lille

    1 shared publication
  • Patrick Duriez

    Degenerative and Vascular Disorders, Faculty of Medicine, Univ. Lille, F-59000 Lille, France

    1 shared publication
  • Sevser Sahpaz

    University of Lille, INRAE, Liège, UPJV, JUNIA, Artois, Littoral Côte d’Opale,UMR Transfrontalière BioEcoAgro,Villeneuve-d'Ascq,France, France

    1 shared publication

Latest Publications

  • Open Access

    Natural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cells

    by Françoise Martin-Nizard, Sevser Sahpaz, Abdelmejid Kandoussi, Marie Carpentier, Jean-Charles Fruchart, Patrick Duriez, François Bailleul

    There is increasing evidence that oxidized low-density lipoproteins (Ox-LDL) might be involved in the pathogenesis of atherosclerosis and it has been reported that polyphenols inhibit LDL peroxidation and atherosclerosis. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide isolated from endothelial cells and it induces smooth muscle cell proliferation. ET-1 secretion is increased in atheroma and induces deleterious effects such as vasospasm and atherosclerosis. The goal of this study was to test the effect of four natural phenolic compounds against copper-oxidized LDL (Cu-LDL)-induced ET-1 liberation by bovine aortic endothelial cells (BAEC). The tested compounds were phenylpropanoid glycosides previously isolated from the aerial parts of Marrubium vulgare L. (acteoside 1, forsythoside B 2, arenarioside 3 and ballotetroside 4). ET-1 secretion increased when cells were incubated with Cu-LDL but the compounds 1–4 inhibited this increase. These results were confirmed by quantitative-polymerase chain reaction (QPCR) analysis. Since ET-1 plays an important role in atherosclerosis development, our work suggests that the tested phenylpropanoids could have a beneficial effect in inhibiting atherosclerosis development.